Compounds > tyrosine

tyrosine and Thrombosis

tyrosine has been researched along with Thrombosis in 108 studies

Research

Studies (108)

TimeframeStudies, this research(%)All Research%
pre-19905 (4.63)18.7374
1990's12 (11.11)18.2507
2000's50 (46.30)29.6817
2010's37 (34.26)24.3611
2020's4 (3.70)2.80

Authors

AuthorsStudies
Gaidukova, KA; Gurova, NA; Khaliullin, FA; Kucheryavenko, AF; Pavlov, VN; Samorodov, AV; Sirotenko, VS; Spasov, AA1
Esposito, G; Ettori, F; Ferlini, M; Lettieri, C; Marchese, A; Musumeci, G; Passamonti, E; Pierini, S; Rigattieri, S; Romano, M; Tarantini, G; Testa, L; Tiberti, G1
Heemskerk, JWM1
Chu, E; Diallo, F; Emani, S; Emani, SM; Pereira, LM; Piekarski, BL; Thiagarajan, R; Wesley, MC1
Çavuşoğlu, Y; Iskenderov, K; Mutlu, F; Şenol, U; Tahmazov, S; Ulus, T1
Choudhary, MI; Moin, SF; Waheed, H1
Chourdakis, E; Hahalis, G; Koniari, I; Kounis, NG; Patsouras, N; Roumeliotis, A; Soufras, G; Tsigkas, G1
Brennan, SO; Chitlur, M1
López, JA1
Karnicki, K; McBane, RD; Wysokinski, WE1
Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY1
Çakıcı, M; Cetin, M; Polat, M; Suner, A1
Austin, D; Christie, J; de Belder, MA; Hennigan, B; Mackay, DF; Morley, R; Oldroyd, KG; Pell, JP1
Natarajan, D1
Heemskerk, JW; Lancé, MD; Lionikiene, AS; Mastenbroek, TG; Mutch, NJ; Swieringa, F; van der Meijden, PE; Whyte, CS1
Baek, JY; Chae, YH; Chang, TS; Jang, JY; Min, JH; Wang, SB; Yu, DY1
Harmon, C; King, S; Short, M1
Ahn, JH; Chang, IB; Jun, HS; Kim, JH; Oh, JK; Song, JH1
Dreysse, S; Falk, V; Kaufmann, F; Krabatsch, T; Kretzschmar, A; Müller, M; Pergantis, P; Pieri, M; Potapov, EV; Scandroglio, AM1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD1
Cao, Z; Gao, L; Zhang, H1
Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q1
Dembo, L; Lovett, M; O'Driscoll, G; Thomas, MD; Wood, C1
Abrams, CS; Bezman, NA; Brass, LF; Jordan, MS; Kahn, ML; Koretzky, GA; Lian, L1
Burke, A; Chernysh, I; Fitzgerald, GA; Heijnen, HF; Ischiropoulos, H; Koliakos, G; Liebler, DC; Nagaswami, C; Parastatidis, I; Stamer, S; Thomson, L; Visser, J; Weisel, JW1
Beiras-Fernandez, A; Jiru, P; Kowert, A; Reichart, B; Schmoeckel, M; Spannagl, M; Weis, M1
Adamo, MF; Alagha, A; Chubb, AJ; Moman, E; Nolan, KB1
Chiariello, M; D'andrea, C; Esposito, G; Piscione, F1
Beresford-Cleary, NJ; Chelliah, R; Connolly, TM; Cortas, K; Daga, S; Feuerstein, GZ; Fox, KA; Lucking, AJ; Newby, DE; Tattersall, L1
Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC1
Bates, ER; Chetcuti, S; Grossman, PM; Gurm, HS; Meier, P; Tamhane, U1
Atherton, RE; Gibbins, JM; Jones, CI; Kaiser, WJ; Moraes, LA; Sage, T; Spyridon, M1
Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W1
Boissinot, M; Cleyrat, C; Girodon, F; Harousseau, JL; Hermouet, S; Issa, JP; Jelinek, J; Ponge, T1
Lin, X; Liu, Y; Ni, Z; Wan, X; Yang, X; Zhang, L; Zhang, Z1
Anselmi, M; Bolognese, L; Bressers, M; Bristot, L; Campo, G; Colangelo, S; De Cesare, N; Gambetti, S; Garcia-Garcia, HM; Garg, S; Monti, M; Moreno, R; Parrinello, G; Rodriguez, AE; Sarno, G; Serruys, PW; Valgimigli, M1
Chen, K; Febbraio, M; Li, W; Major, J; Rahaman, SO; Silverstein, RL1
Dziegielewski, P; Fu Zhu, L; Harris, J; Seikaly, H; Singh, P1
Cheng, CF; Cheng, WT; Kikuchi, T; Lian, WS; Lin, H1
Celikel, R; Jing, H; McClintock, RA; Mendolicchio, GL; Moore, KL; Roberts, JR; Ruggeri, ZM; Varughese, KI; Zarpellon, A1
Schneider, DJ1
Badenhorst, PN; Lamprecht, S; Meiring, SM; Roodt, JP; van Rensburg, WJ1
De Caterina, R; Grove, EL; Huber, K; Kristensen, SD; Moliterno, DJ; Neumann, FJ; Würtz, M1
Cho, JY; Endale, M; Kamruzzaman, SM; Kim, SD; Lee, WM; Park, HJ; Park, JY; Park, MH; Park, TY; Rhee, MH1
Aksakal, E; Inci, S; Karakelleoğlu, S; Sevimli, S1
Davutoglu, V; Ercan, S; Ozer, O; Sari, I; Yuce, M1
Bellandi, F; Cutlip, D; De Luca, G; Dudek, D; Emre, A; Gabriel, HM; Gibson, CM; Gyongyosi, M; Huber, K; Maioli, M; Noc, M; Rakowski, T; Secco, GG; van 't Hof, AW; Zeymer, U; Zorman, S1
Bender, M; Bösl, M; Braun, A; Gupta, S; Hermanns, HM; Morowski, M; Nagy, Z; Nieswandt, B; Premsler, T; Sickmann, A1
Boylan, B; Cooley, BC; Gao, C; Hayes, V; McKenzie, SE; Newman, DK; Newman, PJ; Poncz, M; Rauova, L; Zhi, H1
Ambrosini, V; Battaglia, S; Cioppa, A; Lo Muzio, L; Rubino, P; Salemme, L; Sorropago, G; Tesoria, T1
Adewuya, O; Bian, K; Irie, Y; Murad, F; Onigu-Otite, E1
Azarbal, B; Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V1
CHAMBERS, DA; SALZMAN, EW1
Harrington, RA; Nguyen, CM1
Dai, W; Kloner, RA1
Dubois, C; Reigner, SC; Riederer, MA; Steiner, B1
Goto, S; Ishida, H; Tamura, N1
Allie, AA; Allie, DE; Allie, SD; Chaisson, GA; Fail, PS; Hebert, CJ; Keller, VA; Khan, MA; Khan, MH; Lirtzman, MD; Mitran, EV; Stagg, SJ; Vitrella, DA; Walker, CM; Wyatt, CH1
Gibbins, JM; Hubbard, GP; Lovegrove, JA; Wolffram, S1
del Conde, I; Kleiman, NS; López, JA; Nabi, F; Thiagarajan, P; Tonda, R1
Eberli, FR; Hess, OM; Locher, S; Meier, B; Remondino, A; Rey, C; Seiler, C; Togni, M; Tüller, D; Wenaweser, P; Windecker, S1
Cohen, EA; Fort, S; Godin-Edgecombe, M; Madan, M; Naqvi, SZ; Paradiso-Hardy, FL; Phillips, AM; Radhakrishnan, S; Reis, M; Shanmugasegaram, S; Sparling, C1
Concannon, MJ; Farias, CL; Kazmier, FR; Puckett, CL; Yates, YJ1
Biscione, C; Crea, F; De Vita, M; Maria Leone, A; Mongiardo, R; Niccoli, G; Rebuzzi, A1
Cardaioli, P; Giordan, M; Magro, B; Maronati, L; Rigatelli, G; Roncon, L; Zonzin, P1
Goto, S; Ishida, H; Ruggeri, ZM; Tamura, N1
Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J1
Burns, G; Meola, S; Mohammad, S; Solen, K; Sukavaneshvar, S1
Fontana, P1
Bacchetti, T; Mazzanti, L; Moroni, C; Nanetti, L; Provinciali, L; Raffaelli, F; Silvestrini, M; Taffi, R; Vignini, A1
De Maeyer, B; De Maeyer, M; Deckmyn, H; Fontayne, A; Matsushita, T; Yamashita, M1
Chung, TL; Holton, LH; Pumplin, DW; Rodriguez, ED; Silverman, RP; Taylor, JA1
Bittmann, I; Brandl, U; Brenner, P; Burdorf, L; Erhardt, M; Hammer, C; Jöckle, H; Michel, S; Mordstein, V; Reichart, B; Rössle, M; Schmoeckel, M; Thein, E1
Kim, DJ; Lee, KO; Lee, KY; Seo, KD1
Allegretto, N; Barbera, F; Bird, JE; Giancarli, MR; Ogletree, ML; Schumacher, WA; Seiffert, D; Wong, P1
Głowiński, S; Worowski, K1
Asai, F; Nakashima, M; Takiguchi, Y; Wada, K1
Baumgartner, HR; Kirchhofer, D; Steiner, B; Tschopp, TB1
Cook, JJ; Holahan, MA; Lynch, JJ; Lynch, RJ; Mellott, MJ; Ramjit, DR; Sitko, GR; Stabilito, II; Stranieri, MT; Zhang, G1
André, P; Arbeille, B; Bal dit Sollier, C; Caen, JP; Drouet, LO; Drouet, V; Hainaud, P1
Anderson, KM; Coller, BS; Weisman, HF1
Bidmon, HJ; Buchkremer-Ratzmann, I; Mayer, B; Witte, OW; Wu, J; Zilles, K1
Brosstad, F; Goggin, T; Lehne, G; Midtvedt, K; Nordal, KP1
Kleiman, NS1
Edmunds, LH; Gorman, JH; Hiramatsu, Y; Rao, AK; Sun, L1
Dunn, A1
Atar, S; Birnbaum, Y; Luo, H; Nagai, T; Siegel, RJ1
Aronoff, GR; Blankenship, KA; Dawson, CB; Dean, WL1
Ali, A; Grady, KJ; Patil, S; Schreiber, TL1
Mohammad, SF; Solen, KA; Sukavaneshvar, S1
Collinson, J; Flather, M; Gomma, A; Purcell, H1
Cap, A; Cohen, R; Eberhardt, RT; Farber, HW; Forgione, MA; Goldschmidt-Clermont, PJ; Heydrick, S; Klings, ES; Leopold, JA; Loscalzo, J; Moldovan, NI; Rudd, MA; Stark, R; Trolliet, M; Yaghoubi, M1
Eto, K; Goto, S; Handa, S; Ichikawa, N; Isshiki, T; Kim, JY; Nagaoka, Y; Sakakibara, M; Shimazaki, T; Yoshida, M1
Goto, S; Handa, M; Ikeda, Y; Murata, M1
Arnold, N; Bullens, SL; Bunting, S; Chamberlain, J; Chico, TJ; Crossman, DC; Francis, SE; Gadek, TR; Gunn, J; Horton, M; Knolle, J; Lipari, MT; Peyman, A; Quan, C; Shepherd, L; Stilz, HU1
Bassand, JP1
Vernon, SM1
Böck, K; Calais, P; Herrlinger, JD; Schommer, B; Schröder, J1
Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK1
Aulich, A; Junghans, U; Seitz, RJ; Siebler, M; Wittsack, HJ1
Galli, M1
Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V1
Hirata, K; Isobe, M; Katsuramaki, T; Kimura, H; Kimura, Y; Matsuno, T; Meguro, M; Nagayama, M; Nui, A1
Henry, RG; Little, JW; McIntosh, BA; Miller, CS1
Budzynski, AZ; Marder, VJ1
Murray, M; Smith, GF1
Kopper, PH; Nelson, DL1

Reviews

14 review(s) available for tyrosine and Thrombosis

ArticleYear
Snake Venom: From Deadly Toxins to Life-saving Therapeutics.
    Current medicinal chemistry, 2017, Volume: 24, Issue:17

    Topics: Animals; Anticoagulants; Batroxobin; Blood Coagulation; Captopril; Peptides; Snake Venoms; Snakes; Thrombosis; Tirofiban; Toxins, Biological; Tyrosine

2017
Glycoprotein IIb/IIIa inhibitors: The resurgence of tirofiban.
    Vascular pharmacology, 2016, Volume: 78

    Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Thrombosis; Tirofiban; Tyrosine

2016
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
    Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2009
Current issues with glycoprotein IIb-IIIa antagonists.
    Current drug targets, 2011, Volume: 12, Issue:12

    Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Anticoagulants; Eptifibatide; Hemostasis; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2011
Contemporary use of glycoprotein IIb/IIIa inhibitors.
    Thrombosis and haemostasis, 2012, Volume: 107, Issue:2

    Topics: Abciximab; Acute Coronary Syndrome; Angioplasty; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Thrombosis; Tirofiban; Tyrosine

2012
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:6

    Topics: Abciximab; Angioplasty; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Restenosis; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombosis; Tirofiban; Tyrosine

2003
[Update on antithrombotic treatments in arterial diseases].
    Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97

    Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2007
The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
    Haemostasis, 1996, Volume: 26 Suppl 4

    Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombosis; Tirofiban; Tyrosine

1996
Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists.
    Coronary artery disease, 1998, Volume: 9, Issue:9

    Topics: Abciximab; Acetates; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

1998
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
    Haemostasis, 2000, Volume: 30 Suppl 3

    Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor

2000
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
    Haemostasis, 2000, Volume: 30 Suppl 2

    Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2000
Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
    Cardiology clinics, 2001, Volume: 19, Issue:2

    Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Artery Bypass; Dalteparin; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Nadroparin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Transaminases; Tyrosine

2001
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
    Perfusion, 2001, Volume: 16, Issue:5

    Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine

2001
Antithrombotic agents: implications in dentistry.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 93, Issue:5

    Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin

2002

Trials

5 trial(s) available for tyrosine and Thrombosis

ArticleYear
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation].
    Zhonghua wei zhong bing ji jiu yi xue, 2013, Volume: 25, Issue:5

    Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin

2013
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    American heart journal, 2016, Volume: 177

    Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine

2016
Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Jul-31, Volume: 22

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Combined Modality Therapy; Coronary Angiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2016
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:12

    Topics: Blood Platelets; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Collagen; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Female; Flavonols; Glucosides; Humans; Immunoblotting; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Quercetin; Signal Transduction; Thrombosis; Time Factors; Tyrosine

2004
Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial).
    The American journal of cardiology, 2005, Jun-01, Volume: 95, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Drug Therapy, Combination; Elective Surgical Procedures; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Integrin alpha2; Integrin beta3; Male; Membrane Glycoproteins; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2005

Other Studies

89 other study(ies) available for tyrosine and Thrombosis

ArticleYear
Antithrombotic Activity of the Antiplatelet Agent Angipur on the Model of Arterial Thrombosis in Rats with Isoproterenol-Induced Myocardial Infarction.
    Bulletin of experimental biology and medicine, 2022, Volume: 172, Issue:3

    Topics: Animals; Fibrinolytic Agents; Isoproterenol; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis; Tyrosine

2022
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry.
    Journal of interventional cardiology, 2022, Volume: 2022

    Topics: Aged; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Reperfusion; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2022
More than reverting tyrosine kinases.
    Blood, 2022, 09-01, Volume: 140, Issue:9

    Topics: Humans; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Thrombosis; Tyrosine

2022
Platelet Inhibition With IV Glycoprotein IIb/IIIa Inhibitor to Prevent Thrombosis in Pediatric Patients Undergoing Aortopulmonary Shunting.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2020, Volume: 21, Issue:6

    Topics: Child; Humans; Pharmaceutical Preparations; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombosis; Treatment Outcome; Tyrosine

2020
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2017, Volume: 45, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Thrombosis; Tirofiban; Tyrosine

2017
Perioperative Management of Dual Antiplatelet Therapy.
    Journal of cardiothoracic and vascular anesthesia, 2018, Volume: 32, Issue:3

    Topics: Aspirin; Elective Surgical Procedures; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine

2018
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:6

    Topics: Afibrinogenemia; Aspartic Acid; Binding Sites; Chromatography, High Pressure Liquid; Dimerization; Fibrinogen; Gene Deletion; Genetic Variation; Histidine; Humans; Infant; Male; Mutation; Phenotype; Sequence Analysis, DNA; Thrombosis; Tyrosine

2013
The platelet Fc receptor: a new role for an old actor.
    Blood, 2013, Mar-07, Volume: 121, Issue:10

    Topics: Animals; Blood Platelets; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine

2013
Platelet recruitment to venous stent thrombi.
    Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:4

    Topics: Acetates; Animals; Blood Platelets; Female; Iliac Vein; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Swine; Thrombosis; Tyrosine

2013
Giant left atrial appandage thrombus due to atrial fibrillation: successful treatment with warfarin.
    Platelets, 2014, Volume: 25, Issue:4

    Topics: Atrial Appendage; Atrial Fibrillation; Female; Humans; Platelet Aggregation Inhibitors; Thrombosis; Tyrosine

2014
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 10, Issue:10

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Survival Analysis; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2015
Acute thrombosis during left main stenting using tap technique in a patient presenting with non-ST-segment elevation acute coronary syndrome.
    Cardiovascular revascularization medicine : including molecular interventions, 2015, Volume: 16, Issue:4

    Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Drug Combinations; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2015
Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
    Blood, 2015, Apr-16, Volume: 125, Issue:16

    Topics: Blood Platelets; Crotalid Venoms; Fibrin; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Flow Cytometry; Hemostatics; Hirudins; Lectins, C-Type; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Protein Binding; Rheology; Shear Strength; Thrombin; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine; Urokinase-Type Plasminogen Activator

2015
Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function.
    The Journal of biological chemistry, 2015, May-01, Volume: 290, Issue:18

    Topics: Animals; Antioxidants; Blood Platelets; Carotid Artery Diseases; Collagen; Hydrogen Peroxide; Membrane Microdomains; Mice; Peroxiredoxins; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Reactive Oxygen Species; Signal Transduction; Thrombosis; Tyrosine

2015
Thrombus remnant despite intra-arterial thrombolysis for thrombus formation during endovascular treatment of ruptured cerebral aneurysms: Does it harm?
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2016, Volume: 22, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Cerebral Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Male; Middle Aged; Stents; Thrombolytic Therapy; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2016
Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.
    Journal of the American College of Cardiology, 2016, 06-14, Volume: 67, Issue:23

    Topics: Algorithms; Equipment Design; Equipment Failure; Female; Fibrinolytic Agents; Heart-Assist Devices; Humans; Male; Middle Aged; Retrospective Studies; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2016
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
    BioMed research international, 2016, Volume: 2016

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2016
Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:8

    Topics: Adult; Anticoagulants; Aspirin; Female; Heart-Assist Devices; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Warfarin

2008
Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo.
    The Journal of experimental medicine, 2008, Aug-04, Volume: 205, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Blood Platelets; CD36 Antigens; Female; Genetic Complementation Test; Integrins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutagenesis, Site-Directed; Phospholipase C gamma; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein-Tyrosine Kinases; Signal Transduction; Thrombosis; Tyrosine

2008
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
    The Journal of biological chemistry, 2008, Dec-05, Volume: 283, Issue:49

    Topics: Adolescent; Adult; Fibrin; Fibrinogen; Humans; Microscopy, Immunoelectron; Middle Aged; Nitrogen; Oxidative Stress; Protein Processing, Post-Translational; Protein Structure, Tertiary; Risk Factors; Thrombosis; Tyrosine

2008
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
    The Annals of thoracic surgery, 2009, Volume: 87, Issue:2

    Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2009
Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.
    Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

    Topics: Arginine; Aspirin; Carboxylic Acids; Catalytic Domain; Chemistry, Pharmaceutical; Drug Design; Esters; Humans; Platelet Activation; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Serine; Thrombosis; Tyrosine

2009
Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:11

    Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug Administration Schedule; Embolism; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Saphenous Vein; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2009
P-selectin antagonism reduces thrombus formation in humans.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:11

    Topics: Adolescent; Adult; Blood; Cells, Cultured; Cross-Over Studies; Double-Blind Method; Humans; Hydroxyquinolines; P-Selectin; Perfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Young Adult

2009
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
    Free radical biology & medicine, 2010, Jan-15, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine

2010
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Anilides; Animals; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; PPAR gamma; Prostaglandin D2; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Spectrometry, Fluorescence; Syk Kinase; Thiazolidinediones; Thrombosis; Time Factors; Tyrosine

2010
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
    Journal of applied physiology (Bethesda, Md. : 1985), 2010, Volume: 108, Issue:5

    Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation

2010
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5.
    Leukemia, 2010, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Animals; B-Lymphocytes; Base Sequence; Blotting, Western; Case-Control Studies; Cell Line; Colony-Forming Units Assay; Female; Genotype; Humans; Janus Kinase 2; Mice; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Phenotype; Phosphorylation; Polycythemia; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; STAT5 Transcription Factor; Thrombosis; Tyrosine; Young Adult

2010
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011, Volume: 17, Issue:5

    Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolim
    JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2011
Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.
    Blood, 2011, May-26, Volume: 117, Issue:21

    Topics: Animals; Blood Platelets; Blotting, Western; Carotid Artery Thrombosis; Dietary Fats; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hyperlipidemias; Immunoprecipitation; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-vav; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; src-Family Kinases; Thrombosis; Tyrosine

2011
Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.
    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2011, Volume: 40 Suppl 1

    Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Drug Therapy, Combination; Fascia; Fibrinolytic Agents; Follow-Up Studies; Free Tissue Flaps; Head and Neck Neoplasms; Heparin; Microsurgery; Neoplasms, Experimental; Plastic Surgery Procedures; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Rats; Rats, Sprague-Dawley; Skin Transplantation; Therapeutic Irrigation; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine; Wound Healing

2011
Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.
    Journal of biomedical science, 2011, Apr-15, Volume: 18

    Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrosis; Granulocyte Colony-Stimulating Factor; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Thrombosis; Tirofiban; Tyrosine

2011
Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, May-24, Volume: 108, Issue:21

    Topics: Binding Sites; Hemostasis; Humans; Immobilized Proteins; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Protein Structure, Tertiary; Prothrombin; Thrombin; Thrombosis; Tyrosine

2011
Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates.
    Clinical and experimental medicine, 2012, Volume: 12, Issue:4

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Anticoagulants; Disease Models, Animal; Immunoglobulin Fab Fragments; Primates; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2012
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
    British journal of pharmacology, 2012, Volume: 167, Issue:1

    Topics: Adenosine Triphosphate; Animals; Blood Coagulation; Calcium; Cell Adhesion Molecules; Collagen; Cyclic AMP; Cyclic GMP; Ginsenosides; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Mitogen-Activated Protein Kinases; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane A2; Tyrosine

2012
Acute myocardial infarction during the early postpartum period successfully treated with tirofiban.
    European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 1

    Topics: Acute Disease; Adult; Coronary Angiography; Electrocardiography; Heart Valve Prosthesis; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platelet Aggregation Inhibitors; Postpartum Period; Thrombosis; Tirofiban; Tyrosine

2012
Huge left atrial appendage thrombus in a patient with atrial fibrillation: successful treatment with tirofiban.
    Platelets, 2013, Volume: 24, Issue:4

    Topics: Aged; Atrial Appendage; Atrial Fibrillation; Female; Humans; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2013
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:7

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Electrocardiography; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2012
CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
    Circulation research, 2012, Nov-09, Volume: 111, Issue:11

    Topics: Animals; Blood Coagulation Tests; Blood Platelets; Blotting, Western; Calcium; Collagen; Female; Gene Expression; Immunoreceptor Tyrosine-Based Activation Motif; Inositol 1,4,5-Trisphosphate; LIM Domain Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Microscopy, Electron, Transmission; Phosphorylation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thrombosis; Transcription Factors; Tyrosine

2012
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
    Blood, 2013, Mar-07, Volume: 121, Issue:10

    Topics: Animals; Arterioles; Blood Platelets; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine; Veins

2013
Percutaneous femoral artery angioplasty with stent-in-stent technique and tirofiban administration.
    The Journal of invasive cardiology, 2002, Volume: 14, Issue:10

    Topics: Angioplasty, Balloon; Female; Femoral Artery; Fibrinolytic Agents; Humans; Middle Aged; Recurrence; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2002
Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide.
    Nitric oxide : biology and chemistry, 2003, Volume: 8, Issue:1

    Topics: Aneurysm; Animals; Blotting, Western; Cell Wall; Coronary Vessels; Disease Models, Animal; Hemorrhage; Immunohistochemistry; Inflammation; Lacticaseibacillus casei; Macrophages; Male; Mice; Mucocutaneous Lymph Node Syndrome; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Thrombosis; Time Factors; Tyrosine; Vasculitis

2003
Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:4

    Topics: Animals; Arteriovenous Shunt, Surgical; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2003
INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY SUBSTITUTED AMINO-ACIDS.
    Nature, 1964, Nov-14, Volume: 204

    Topics: Adenine Nucleotides; Adenosine Diphosphate; Alanine; Alkylation; Amino Acids; Aminocaproates; Aminocaproic Acid; Arginine; Blood Platelets; Butyrates; Glutamine; Glycine; Guanidines; Leucine; Pharmacology; Phenylalanine; Platelet Aggregation; Proline; Research; Thrombosis; Tyrosine

1964
Glycoprotein IIb/IIIa inhibitors and no-reflow.
    Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2

    Topics: Animals; Coronary Circulation; Fibrinolytic Agents; Humans; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2004
Thrombin binding to GPIbalpha induces integrin alphaIIbbeta3 dependent platelet adhesion to fibrin in ex vivo flowing whole blood.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:2

    Topics: Acetates; Anticoagulants; Blood; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Membrane Glycoproteins; Membrane Proteins; Oligopeptides; Peptide Fragments; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombin; Thrombosis; Tyrosine

2004
Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
    Journal of the American College of Cardiology, 2004, Jul-21, Volume: 44, Issue:2

    Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Collagen; Eptifibatide; Fibrinolytic Agents; Hemorheology; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Peptides; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombosis; Tirofiban; Tyrosine

2004
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2004, Volume: 11, Issue:4

    Topics: Aged; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemia; Leg; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tenecteplase; Thrombolytic Therapy; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2004
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:5

    Topics: Apoptosis; Blood Platelets; Cell Membrane; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Vitro Techniques; Membrane Glycoproteins; Monocytes; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Activation; Solubility; Thrombin; Thrombosis; Tyrosine

2005
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
    European heart journal, 2005, Volume: 26, Issue:12

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Vessel Prosthesis; Death, Sudden, Cardiac; Emergency Treatment; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Survival Analysis; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2005
The effect of tirofiban on microvascular thrombosis: crush model.
    Plastic and reconstructive surgery, 2005, Volume: 116, Issue:1

    Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Femoral Artery; Isotonic Solutions; Microsurgery; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Ringer's Lactate; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2005
Delayed stenting of a thrombotic saphenous vein graft after intravenous tirofiban pretreatment.
    International journal of cardiology, 2006, Jun-07, Volume: 110, Issue:1

    Topics: Aged; Coronary Disease; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Thrombosis; Tirofiban; Tyrosine

2006
Iliac artery thrombosis after aortic balloon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting.
    International journal of cardiology, 2006, Oct-10, Volume: 112, Issue:3

    Topics: Aged; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Iliac Artery; Infusions, Intra-Arterial; Intra-Aortic Balloon Pumping; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2006
Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1

    Topics: Adenosine Monophosphate; Blood Platelets; Calcium Channel Blockers; Calcium Signaling; Collagen; Humans; In Vitro Techniques; Lanthanum; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thrombosis; Tirofiban; Tyrosine

2006
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Circulation research, 2006, Jul-07, Volume: 99, Issue:1

    Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2006
Mitigation of device-associated thrombosis and thromboembolism using combinations of heparin and tirofiban.
    The journal of extra-corporeal technology, 2006, Volume: 38, Issue:3

    Topics: Animals; Anticoagulants; Drug Therapy, Combination; Heparin; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Sheep; Stents; Thromboembolism; Thrombosis; Tirofiban; Tyrosine

2006
Reactive oxygen species plasmatic levels in ischemic stroke.
    Molecular and cellular biochemistry, 2007, Volume: 303, Issue:1-2

    Topics: Aged; Atherosclerosis; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Reactive Oxygen Species; Thrombosis; Tyrosine

2007
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha.
    The Journal of biological chemistry, 2007, Aug-10, Volume: 282, Issue:32

    Topics: Amino Acid Sequence; Amino Acids; Antibodies; Antibodies, Monoclonal; Binding Sites, Antibody; Chemistry, Pharmaceutical; Drug Design; Epitope Mapping; Epitopes; Membrane Glycoproteins; Membrane Proteins; Molecular Conformation; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Glycoprotein GPIb-IX Complex; Software; Thrombosis; Tyrosine

2007
Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.
    Plastic and reconstructive surgery, 2007, Volume: 120, Issue:5

    Topics: Anastomosis, Surgical; Animals; Anticoagulants; Aspirin; Drug Therapy, Combination; Heparin; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2007
Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Transplantation, 2007, Dec-27, Volume: 84, Issue:12

    Topics: Adult; Animals; Animals, Genetically Modified; Antibodies; CD55 Antigens; Complement C3; Complement C4; Creatine Kinase; Disaccharides; Fibrin; Fibrinolytic Agents; Heart; Heart Transplantation; Humans; Male; Myocardium; Swine; Thrombosis; Tirofiban; Transplantation, Heterologous; Tyrosine

2007
Rescue use of tirofiban for acute carotid in-stent thrombosis.
    Yonsei medical journal, 2008, Feb-29, Volume: 49, Issue:1

    Topics: Acute-Phase Reaction; Angiography; Carotid Artery Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stents; Thrombosis; Tirofiban; Tyrosine

2008
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
    Thrombosis research, 2008, Volume: 123, Issue:1

    Topics: Animals; Anticoagulants; Arginine; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Chlorides; Ferric Compounds; Guinea Pigs; Hemostasis; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombosis; Tirofiban; Tyrosine

2008
Cathepsin D activity and protein degradation products content in the walls of varicose veins of the lower limbs.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1981, Volume: 13, Issue:3

    Topics: Adult; Cathepsins; Female; Humans; Male; Middle Aged; Proteins; Saphenous Vein; Thrombosis; Tyrosine; Varicose Veins

1981
Comparison of antithrombotic effects of GPIIb-IIIa receptor antagonist and TXA2 receptor antagonist in the guinea-pig thrombosis model: possible role of TXA2 in reocclusion after thrombolysis.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:4

    Topics: Acetates; Animals; Biphenyl Compounds; Femoral Artery; Guinea Pigs; Heptanoic Acids; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Thromboxane; Thrombosis; Thromboxane A2; Tyrosine

1995
Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
    Blood, 1995, Nov-15, Volume: 86, Issue:10

    Topics: Acetates; Anticoagulants; Blood Coagulation; Blood Platelets; Collagen; Enzyme Activation; Factor Xa; Fibrin; Fibrinopeptide A; Hemorheology; Humans; In Vitro Techniques; Macromolecular Substances; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1995
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:1

    Topics: Adenosine Diphosphate; Animals; Coronary Circulation; Dogs; Female; Hemostasis; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine

1995
Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:1

    Topics: Acetates; Animals; Anticoagulants; Capillary Action; Collagen; Fibrin; Guinea Pigs; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1996
Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions.
    Neuroscience, 1998, Volume: 82, Issue:2

    Topics: Animals; Cerebral Infarction; Immunohistochemistry; Ischemic Attack, Transient; Isoenzymes; Lectins; Male; NADPH Dehydrogenase; Nitric Oxide Synthase; Rats; Rats, Wistar; Somatosensory Cortex; Thrombosis; Tyrosine

1998
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:6

    Topics: Acetates; Adenosine Diphosphate; Adult; Aged; Bleeding Time; Creatinine; Female; Half-Life; Hematoma; Humans; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1998
Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:1

    Topics: Animals; Cardiopulmonary Bypass; Fibrinolytic Agents; Intraoperative Complications; Papio; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis; Tirofiban; Tyrosine

1999
Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
    Connecticut medicine, 1999, Volume: 63, Issue:8

    Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

1999
Lamifiban.
    Drugs in R&D, 1999, Volume: 1, Issue:5

    Topics: Acetates; Animals; Dogs; Guinea Pigs; Haplorhini; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis; Tyrosine

1999
Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
    Thrombosis research, 1999, Dec-15, Volume: 96, Issue:6

    Topics: Albumins; Blood Coagulation; Contrast Media; Fibrin; Fibrinolytic Agents; Fluorocarbons; Heparin; Humans; In Vitro Techniques; Sodium Chloride; Solubility; Sonication; Stents; Thrombosis; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tyrosine

1999
Tyrosine phosphorylation of human platelet plasma membrane Ca(2+)-ATPase in hypertension.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 1

    Topics: Adult; Blood Platelets; Calcium-Transporting ATPases; Case-Control Studies; Cell Membrane; Female; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Phosphorylation; Risk Factors; Thrombosis; Tyrosine

2000
Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2000, Volume: 49, Issue:2

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Fatal Outcome; Female; Hemoptysis; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Alveoli; Thrombosis; Tirofiban; Tyrosine

2000
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:2

    Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine

2000
The role of tirofiban in acute coronary syndromes.
    International journal of clinical practice, 2000, Volume: 54, Issue:2

    Topics: Angina, Unstable; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Tyrosine

2000
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.
    The Journal of clinical investigation, 2000, Volume: 106, Issue:4

    Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Cystathionine beta-Synthase; Dinoprost; Disease Models, Animal; Endothelium, Vascular; F2-Isoprostanes; Heterozygote; Humans; Hyperhomocysteinemia; In Vitro Techniques; Lipid Peroxides; Mice; Mice, Mutant Strains; Nitroprusside; Reactive Oxygen Species; Risk Factors; Thrombosis; Tyrosine; Vasodilation

2000
[Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Journal of cardiology, 2000, Volume: 36, Issue:2

    Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Collagen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Microscopy, Fluorescence; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2000
Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.
    Circulation, 2001, Feb-27, Volume: 103, Issue:8

    Topics: Acetates; Angioplasty, Balloon, Coronary; Animals; Cell Adhesion; Disease Models, Animal; Immunohistochemistry; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Swine; Thrombosis; Tunica Intima; Tyrosine

2001
[Lysis of an extensive thrombus in the internal carotid artery using a glycoprotein IIb/IIIa receptor antagonist].
    Deutsche medizinische Wochenschrift (1946), 2001, Jun-08, Volume: 126, Issue:23

    Topics: Aphasia, Broca; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Paralysis; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking; Thrombosis; Tirofiban; Tomography, X-Ray Computed; Tyrosine

2001
Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Radiology, 2001, Volume: 221, Issue:3

    Topics: Aged; Basilar Artery; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine

2001
Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy.
    Circulation, 2001, Dec-18, Volume: 104, Issue:25

    Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2001
Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
    Circulation, 2002, Apr-23, Volume: 105, Issue:16

    Topics: Animals; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Blood Pressure; Dogs; Eptifibatide; Fibrinolytic Agents; Heart Rate; Heparin; Magnesium Sulfate; P-Selectin; Peptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Time Factors; Tirofiban; Tyrosine

2002
A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver.
    Transplantation, 2002, May-15, Volume: 73, Issue:9

    Topics: Amidines; Animals; Aspartate Aminotransferases; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Hot Temperature; Ischemia; L-Lactate Dehydrogenase; Liver; Liver Circulation; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Reperfusion Injury; Survival Analysis; Swine; Thrombosis; Tissue Distribution; Tyrosine

2002
Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
    Thrombosis et diathesis haemorrhagica, 1975, Dec-15, Volume: 34, Issue:3

    Topics: Amino Acid Sequence; Batroxobin; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Protein Binding; Radioimmunoassay; Retinal Diseases; Retinal Vessels; Thrombophlebitis; Thrombosis; Tyrosine

1975
Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
    Archives of pathology, 1970, Volume: 89, Issue:3

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Binding Sites; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Edetic Acid; Fibrin; Fibrinogen; Glycine; Humans; Immunoelectrophoresis; Models, Biological; Thrombin; Thrombosis; Tyrosine

1970
A new method for lysis of blood clots in vivo.
    Transactions of the Kansas Academy of Science. Kansas Academy of Science, 1966,Spring, Volume: 69, Issue:1

    Topics: Animals; Dogs; Fibrinolytic Agents; Gluconates; Thrombosis; Tyrosine

1966